*By Christian Smith*
Mallory Hagan, crowned Miss America in 2013, wanted to change the stereotypes Americans have about Alabama.
So she decided to run for Congress.
"We are at the bottom of the barrel when it comes to healthcare, when it comes to government transparency, when it comes to education, quality of life. But we are at the top when it comes to corruption," Hagan said in an interview on Cheddar Monday. "So many people have a really awful view of our state, and it's a really beautiful place."
Hagan won the Democratic nomination for Alabama's third congressional district in the June 5 primary. She will take on the 16-year incumbent, Republican Congressman Mike Rogers, in the general election on November 5.
Rogers won his last campaign in 2016 by 34 points over the Democratic challenger Jesse Smith. But despite the district's conservative voting record, Hagan believes she can make inroads by galvanizing local college students who don't normally vote.
"My plan is to engage young people in this process, get them involved in this campaign and show them that their vote and their voice does in fact matter, and that their involvement in politics is crucial to the future of our nation," Hagan said.
At the heart of her campaign is the goal of fixing Alabama's healthcare system. The state has one of the highest infant mortality rates in the country. In 2016, nine out of every 1,000 newborns died before reaching their first birthday, which is a higher rate than many developing nations.
Hagan's critics question whether her experience as Miss America has any relevance in politics. In the 29-year-old's eyes, winning the title and working with charitable causes around the country was the perfect prep for serving in Congress.
"I've represented our nation before, and I'm ready to represent the people of Alabama," Hagan said.
For full interview, [click here](https://cheddar.com/videos/miss-america-takes-on-new-challenge-congress).
A new report from CNBC says Instagram recently reached a new milestone -- 2 billion monthly active users. It comes amid a year of controversy for the photo-sharing app and its parent company, Meta. SocialFlow CEO Jim Anderson joins Cheddar News' Closing Bell to discuss.
There is a new way for investors to bet on cannabis - the AdvisorShares Poseidon Dynamic Cannabis ETF targets about 20 of the biggest names in U.S. cannabis. It comes at a time when it's still difficult for investors to access the space. Cheddar News cannabis reporter Chloe Aiello spoke with co-founder and managing director for Poseidon Investment Management, Emily Paxhia.
Victor Li, an economics professor at the Villanova School of Business, joins Cheddar News' Closing Bell, where he discusses the latest Fed decision and the implications it has on the stock market.
After nearly two years of the pandemic, U.S. consumers are ready to spend big this holiday season. However, shoppers may be faced with limited inventory as the U.S. continues to face shortages of key products and extended order backlogs. Per Hong, partner at consulting firm Kearney, joined Cheddar's Opening Bell to discuss the country's path forward.
The U.S. Government is making its first major move toward encouraging nuclear energy in the U.S., as it pushes toward a sustainable future. Scott Waldman, White House reporter for Politico's E&E News joined Cheddar News to break down the developments. "There's definitely an audience for this now since we're looking at the value of nuclear in terms of climate policy," he said, regarding the prospects for bipartisan support.
CEOs of the top U.S. airlines are set to testify in front of a Senate committee Wednesday. Lawmakers will ask airline executives about how they used pandemic-related federal aid, specifically in light of staffing issues and widespread cancellations. Among those expected to participate are the CEOs of American, United, and Southwest Airlines. David Slotnick, Senior Aviation Business Reporter at The Points Guy, joined Cheddar News to discuss.
Carlo and Baker cover the latest data showing the Omicron wave has likely started, Pfizer's Covid pill, Jan. 6 and a box office rescue attempt courtesy of Spider-Man.
